Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q114716470
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000238.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q114716470
|
035
|
|
|
‡a
(OCoLC)Q114716470
|
100
|
0 |
|
‡a
Jerico Del Rosario
‡c
researcher
‡9
en
|
670
|
|
|
‡a
Author's Epitope-specific airway-resident CD4+ T cell dynamics during experimental human RSV infection
|
670
|
|
|
‡a
Author's Erratum: RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection
|
670
|
|
|
‡a
Author's IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.
|
670
|
|
|
‡a
Author's Interleukin-18 is associated with protection against rhinovirus-induced colds and asthma exacerbations.
|
670
|
|
|
‡a
Author's RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection
|
919
|
|
|
‡a
erratumrsvspecificairwayresidentmemorycd8+tcellsanddifferentialdiseaseseverityafterexperimentalhumaninfection
‡A
Erratum: RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection
‡9
1
|
919
|
|
|
‡a
interleukin18isassociatedwithprotectionagainstrhinovirusinducedcoldsandasthmaexacerbations
‡A
Interleukin-18 is associated with protection against rhinovirus-induced colds and asthma exacerbations.
‡9
1
|
919
|
|
|
‡a
rsvspecificairwayresidentmemorycd8+tcellsanddifferentialdiseaseseverityafterexperimentalhumaninfection
‡A
RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection
‡9
1
|
919
|
|
|
‡a
33dependenttype2inflammationduringrhinovirusinducedasthmaexacerbationsinvivo
‡A
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.
‡9
1
|
919
|
|
|
‡a
epitopespecificairwayresidentcd4+tcelldynamicsduringexperimentalhumanrsvinfection
‡A
Epitope-specific airway-resident CD4+ T cell dynamics during experimental human RSV infection
‡9
1
|
996
|
|
|
‡2
ISNI|0000000070020569
|
996
|
|
|
‡2
PTBNP|251665
|
996
|
|
|
‡2
PTBNP|258202
|
996
|
|
|
‡2
ISNI|000000006779896X
|
996
|
|
|
‡2
ISNI|0000000068003073
|
996
|
|
|
‡2
PTBNP|230284
|
996
|
|
|
‡2
LC|nb2002034649
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|